id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-309813-qojacnli	Lipner, Shari R.	Recommendations for Diagnosis and Treatment of Onychomycosis During the COVID‐19 Pandemic	2020-05-30		.txt	text/plain	527	49	32	1 Prior to the COVID-19 pandemic, clinical examination, dermoscopy, and mycological examination were recommended for all patients with suspected onychomycosis, followed by a discussion of appropriate treatment options. 2 However, with prevalence of COVID-19, non-urgent inperson visits are deferred, and telemedicine may be utilized to address some aspects of onychomycosis diagnosis and treatment. Onychomycosis treatment guidelines prior to the COVID-19 pandemic are no longer applicable. Telemedicine can be used for initial consultation of patients with onychodystrophy and topicals prescribed for tinea pedis if indicated; patients with confirmed onychomycosis can be monitored for clear nail growth and side effects. Confirmatory Testing Prior to Initiating Onychomycosis Therapy Is Cost-Effective Retrospective analysis of adverse events with systemic onychomycosis medications reported to the United States Food and Drug Administration Retrospective analysis of adverse events with topical onychomycosis medications reported to the United States Food and Drug Administration Retrospective Analysis of Laboratory Abnormalities in Patients Prescribed Terbinafine for Onychomycosis	./cache/cord-309813-qojacnli.txt	./txt/cord-309813-qojacnli.txt